Yahoo Canada Web Search

Search results

1. www.nytimes.com › 2024/07/07 › opinionOpinion | All the Alzheimer’s Research We Didn’t Do

   www.nytimes.com › 2024/07/07 › opinion

   20 hours ago · Case closed, many scientists have argued, although drugs that prevent, arrest or reverse symptoms of Alzheimer’s remain on the hypothetical horizon. And there are serious concerns about the new ...

2. en.wikipedia.org › wiki › Alzheimer's_diseaseAlzheimer's disease - Wikipedia

   en.wikipedia.org › wiki › Alzheimer's_disease

   • Cached

   5 days ago · Alzheimer's disease (AD) is a neurodegenerative disease that usually starts slowly and progressively worsens, and is the cause of 60–70% of cases of dementia. The most common early symptom is difficulty in remembering recent events.

3. Images

   • 
   • 
   • 
   • 
   • 

   View all

4. www.nytimes.com › 2024/07/02 › healthNew Drug Approved for Early Alzheimer’s - The New York Times

   www.nytimes.com › 2024/07/02 › health

   5 days ago · A committee of independent advisers to the F.D.A. voted unanimously that the benefits outweigh the risks of donanemab, the newest experimental drug made by Eli Lilly for Alzheimer’s disease.

5. www.cbc.ca › news › healthFDA approves new Alzheimer's drug, offering hope for slower ...

   www.cbc.ca › news › health

   • Cached

   5 days ago · A new Alzheimer's drug, donanemab, is giving new hope to those living with the condition, but it doesn't come without side effects and it's not a cure. Dr. Roger Wong, a clinical professor of...

6. Videos

   • 2:02

     youtube.com

     The Alzheimer Case - Official Trailer

     Nov 17, 2017

     3.9K Views

   • 5:00

     bbc.com

     The world's forgotten first Alzheimer’s patient

     Jan 12, 2016

   • 8:54

     youtube.com

     Alzheimer's disease - plaques, tangles, causes, symptoms & pathology

     Mar 22, 2016

     1.6M Views

   View all

7. apnews.com › article › alzheimers-drug-kisunlaFDA approves a second Alzheimer's drug, Eli Lilly's Kisunla ...

   apnews.com › article › alzheimers-drug-kisunla

   • Cached

   5 days ago · The Food and Drug Administration approved Eli Lilly’s Kisunla on Tuesday for mild or early cases of dementia caused by Alzheimer’s. It’s only the second drug that’s been convincingly shown to delay cognitive decline in patients, following last year’s approval of a similar drug from Japanese drugmaker Eisai.

8. www.scientificamerican.com › custom-media › davosThe New Age of Alzheimer’s | Scientific American

   www.scientificamerican.com › custom-media › davos

   • Cached

   4 days ago · July 4, 2024. Journey through the History of Alzheimer’s Disease. A century after its discovery, scientists are beginning to grasp the complex biology of Alzheimer’s. Now the race is on to...

9. globalnews.ca › news › 10601598FDA approves new Alzheimer’s drug that slows memory decline

   globalnews.ca › news › 10601598

   • Cached

   5 days ago · The U.S. Food and Drug Administration on Tuesday approved Eli Lilly’s treatment for early Alzheimer’s, making it the second therapy for slowing progression of the brain-wasting disease that...